ヘリオスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/03/13 | 1,307 | 1,385 | 1,264 | 1,341 | -73 | -5.2% | 227,700 |
2020/03/12 | 1,454 | 1,496 | 1,378 | 1,414 | -88 | -5.9% | 165,500 |
2020/03/11 | 1,470 | 1,549 | 1,470 | 1,502 | -3 | -0.2% | 123,300 |
2020/03/10 | 1,431 | 1,513 | 1,355 | 1,505 | -16 | -1.1% | 298,800 |
2020/03/09 | 1,601 | 1,606 | 1,502 | 1,521 | -127 | -7.7% | 306,300 |
2020/03/06 | 1,643 | 1,659 | 1,621 | 1,648 | +5 | +0.3% | 147,400 |
2020/03/05 | 1,701 | 1,712 | 1,631 | 1,643 | -42 | -2.5% | 217,200 |
2020/03/04 | 1,688 | 1,691 | 1,648 | 1,685 | -39 | -2.3% | 209,700 |
2020/03/03 | 1,824 | 1,826 | 1,703 | 1,724 | -65 | -3.6% | 218,500 |
2020/03/02 | 1,645 | 1,804 | 1,645 | 1,789 | +120 | +7.2% | 253,600 |
2020/02/28 | 1,618 | 1,747 | 1,618 | 1,669 | -41 | -2.4% | 310,400 |
2020/02/27 | 1,753 | 1,774 | 1,700 | 1,710 | -75 | -4.2% | 213,100 |
2020/02/26 | 1,769 | 1,828 | 1,751 | 1,785 | -6 | -0.3% | 204,800 |
2020/02/25 | 1,754 | 1,825 | 1,740 | 1,791 | -70 | -3.8% | 110,900 |
2020/02/21 | 1,841 | 1,878 | 1,836 | 1,861 | +21 | +1.1% | 116,400 |
2020/02/20 | 1,860 | 1,904 | 1,832 | 1,840 | -9 | -0.5% | 143,500 |
2020/02/19 | 1,801 | 1,888 | 1,801 | 1,849 | +29 | +1.6% | 213,000 |
2020/02/18 | 1,901 | 1,901 | 1,809 | 1,820 | -91 | -4.8% | 270,600 |
2020/02/17 | 1,944 | 1,946 | 1,898 | 1,911 | -46 | -2.4% | 178,600 |
2020/02/14 | 1,957 | 1,960 | 1,902 | 1,957 | +17 | +0.9% | 201,400 |
2020/02/13 | 1,913 | 1,959 | 1,890 | 1,940 | +8 | +0.4% | 162,100 |
2020/02/12 | 1,920 | 1,947 | 1,903 | 1,932 | +11 | +0.6% | 143,500 |
2020/02/10 | 1,906 | 1,934 | 1,895 | 1,921 | +15 | +0.8% | 109,500 |
2020/02/07 | 1,945 | 1,945 | 1,894 | 1,906 | -35 | -1.8% | 118,000 |
2020/02/06 | 1,958 | 1,960 | 1,902 | 1,941 | -14 | -0.7% | 211,200 |
2020/02/05 | 1,938 | 1,960 | 1,920 | 1,955 | +47 | +2.5% | 171,000 |
2020/02/04 | 1,869 | 1,945 | 1,865 | 1,908 | +25 | +1.3% | 197,200 |
2020/02/03 | 1,775 | 1,906 | 1,760 | 1,883 | +65 | +3.6% | 300,900 |
2020/01/31 | 1,843 | 1,876 | 1,813 | 1,818 | -2 | -0.1% | 261,400 |
2020/01/30 | 1,876 | 1,882 | 1,770 | 1,820 | -65 | -3.4% | 533,000 |
2020/01/29 | 1,920 | 1,939 | 1,866 | 1,885 | -62 | -3.2% | 412,400 |
2020/01/28 | 1,987 | 1,990 | 1,851 | 1,947 | -71 | -3.5% | 558,800 |
2020/01/27 | 1,772 | 2,031 | 1,753 | 2,018 | +206 | +11.4% | 1,012,700 |
2020/01/24 | 1,815 | 1,823 | 1,795 | 1,812 | -11 | -0.6% | 165,400 |
2020/01/23 | 1,808 | 1,835 | 1,800 | 1,823 | +23 | +1.3% | 314,600 |
2020/01/22 | 1,778 | 1,813 | 1,767 | 1,800 | +9 | +0.5% | 338,200 |
2020/01/21 | 1,752 | 1,798 | 1,739 | 1,791 | +18 | +1% | 334,600 |
2020/01/20 | 1,708 | 1,782 | 1,680 | 1,773 | +43 | +2.5% | 278,600 |
2020/01/17 | 1,777 | 1,782 | 1,715 | 1,730 | -56 | -3.1% | 293,800 |
2020/01/16 | 1,800 | 1,847 | 1,759 | 1,786 | +19 | +1.1% | 431,500 |
2020/01/15 | 1,729 | 1,768 | 1,718 | 1,767 | +58 | +3.4% | 204,100 |
2020/01/14 | 1,800 | 1,815 | 1,701 | 1,709 | -6 | -0.3% | 472,000 |
2020/01/10 | 1,675 | 1,716 | 1,672 | 1,715 | +104 | +6.5% | 506,700 |
2020/01/09 | 1,550 | 1,617 | 1,545 | 1,611 | +76 | +5% | 395,200 |
2020/01/08 | 1,520 | 1,548 | 1,490 | 1,535 | +20 | +1.3% | 384,800 |
2020/01/07 | 1,500 | 1,530 | 1,498 | 1,515 | +39 | +2.6% | 159,800 |
2020/01/06 | 1,458 | 1,504 | 1,450 | 1,476 | -17 | -1.1% | 155,400 |
2019/12/30 | 1,498 | 1,517 | 1,480 | 1,493 | -3 | -0.2% | 135,800 |
2019/12/27 | 1,461 | 1,518 | 1,456 | 1,496 | +37 | +2.5% | 226,000 |
2019/12/26 | 1,483 | 1,503 | 1,452 | 1,459 | -56 | -3.7% | 472,700 |
1151~
1200
件表示中 / 2309件
類似銘柄と比較する
現在ご覧いただいている「ヘリオス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ヘリオス | 19,600円 | +395.9% | - | 0.00% | - | 5.45倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
オンコリス | 70,300円 | +58.7% | - | 0.00% | - | 12.39倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
Chordia | 24,900円 | - | - | 0.00% | - | 4.08倍 |
|
RNA制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
市場注目の銘柄
チャート関連のコラム